Low-cost, screen-printed carbon sensors have been used to rapidly detect bacteria commonly found in wounds, which could pave the way for a real time medical device.
Impel NeuroPharma, a Seattle-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration last week for its novel nasal spray that treats migraine headaches.